David Hoang's Stock Ratings

Citigroup Analyst

David Hoang is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/24/2024

Overall Average Return

-7.57%

Smart Score

35.7%

Overall Average Return Percentile

23rd

Number of Ratings

23
Buy NowGet Alert
05/10/2024XENEBuy Now
Xenon Pharmaceuticals
$38.4656.01%$62 → $60MaintainsBuyGet Alert
05/09/2024ACADBuy Now
ACADIA Pharmaceuticals
$15.3795.19%$30.19 → $30MaintainsBuyGet Alert
05/07/2024AXSMBuy Now
Axsome Therapeutics
$74.5367.71%$127 → $125MaintainsBuyGet Alert
05/03/2024NBIXBuy Now
Neurocrine Biosciences
$140.646.66%$140 → $150MaintainsNeutralGet Alert
03/26/2024AXSMBuy Now
Axsome Therapeutics
$74.5370.39%$125 → $127MaintainsBuyGet Alert
03/15/2024SLDBBuy Now
Solid Biosciences
$7.78105.66% → $16Initiates → BuyGet Alert
03/12/2024ACADBuy Now
ACADIA Pharmaceuticals
$15.3796.42%$38 → $30.19MaintainsBuyGet Alert
03/07/2024VYGRBuy Now
Voyager Therapeutics
$8.2494.17% → $16Initiates → BuyGet Alert
02/29/2024SRPTBuy Now
Sarepta Therapeutics
$126.4736%$160 → $172MaintainsBuyGet Alert
02/16/2024LBPHBuy Now
Longboard Pharmaceuticals
$18.60115.05% → $40Initiates → BuyGet Alert
02/08/2024NBIXBuy Now
Neurocrine Biosciences
$140.64-0.46%$141 → $140MaintainsNeutralGet Alert
01/04/2024XENEBuy Now
Xenon Pharmaceuticals
$38.4661.21% → $62Initiates → BuyGet Alert
12/13/2023DNLIBuy Now
Denali Therapeutics
$19.4064.95% → $32Initiates → BuyGet Alert
12/13/2023NBIXBuy Now
Neurocrine Biosciences
$140.64-9.7% → $127Initiates → NeutralGet Alert
12/13/2023ACADBuy Now
ACADIA Pharmaceuticals
$15.37147.23% → $38Initiates → BuyGet Alert
12/13/2023SRPTBuy Now
Sarepta Therapeutics
$126.47-10.65% → $113Initiates → BuyGet Alert
12/13/2023AXSMBuy Now
Axsome Therapeutics
$74.5367.71% → $125Initiates → BuyGet Alert
04/26/2023ALNYBuy Now
Alnylam Pharmaceuticals
$149.4247.24% → $220Initiates → NeutralGet Alert
04/26/2023ARWRBuy Now
Arrowhead Pharma
$25.13218.34% → $80Initiates → OutperformGet Alert
04/26/2023SRPTBuy Now
Sarepta Therapeutics
$126.4746.28% → $185Initiates → OutperformGet Alert
03/14/2023PRVBBuy Now
Provention Bio
——$15 → $25DowngradeOutperform → NeutralGet Alert
12/07/2022GOSSBuy Now
Gossamer Bio
$0.62387.01% → $3DowngradeOutperform → NeutralGet Alert
04/01/2022ORTXBuy Now
Orchard Therapeutics
———DowngradeOutperform → NeutralGet Alert